Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.79 |
| ▸ | EBP | Q15125 | 1/20 | 0.79 |
| ▸ | HRH3 | Q9Y5N1 | 12/20 | 0.40 |
| ▸ | MAOB | P27338 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amorolfine SCHEMBL8165433 | 1.00 | ADORA3 (1.00) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| Amorolfine SCHEMBL933541 | 1.00 | ADORA3 (1.00) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| Amorolfine SCHEMBL5579008 | 0.99 | ADORA3 (0.97) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| Amorolfine SCHEMBL36711 | 0.99 | ADORA3 (0.97) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| Amorolfine SCHEMBL1934866 | 0.99 | ADORA3 (0.97) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| Amorolfine SCHEMBL1649004 | 0.97 | ADORA3 (0.95) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| Amorolfine SCHEMBL3820874 | 0.95 | ADORA3 (0.91) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| Amorolfine SCHEMBL23111397 | 0.90 | ADORA3 (0.81) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| SCHEMBL19823129 | 0.90 | ADORA3 (0.81) | ADORA3CHRM1DRD3KCNH2SIGMAR1 | |
| SCHEMBL11164667 | 0.89 | ADORA3 (0.80) | ADORA3CHRM1DRD3KCNH2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8783 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719384-A2 | COMPOUNDS WITH ANTIFUNGAL PROPERTIES | Trustees of Dartmouth College (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260076924-A1 | COMPOSITIONS AND METHODS OF TREATMENT FOR TINEA PEDIS | THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260027255-A1 | Cross-Linked Telechelic Polymer Compositions, Methods of Preparation Thereof, and Methods of Using Same | BETTY YU SKIN TECH ADVISORS LLC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4680240-A1 | METHOD OF TREATING DISORDERS WITH SURF1 MALFUNCTION | Cure Mito Foundation (US) | 2026-01-21 | — | — | EP | claimed |
| US-20260007753-A1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2026-01-08 | — | — | US | claimed |
| US-20250319078-A1 | METHOD FOR SYNERGISTIC ENHANCEMENT OF REMYELINATION VIA MODULATION OF RXR AND A HETERODIMERIC PARTNER | LAIRSON LUKE L (US) | 2025-10-16 | — | — | US | claimed |
| US-12433856-B2 | Petrolatum-based compositions and methods of treatment for onychomycosis | GLOBAL HEALTH SOLUTIONS LLC | 2025-10-07 | — | — | US | claimed |
| US-5696164-A | APPLYING MIXTURE OF UREA AND SULFHYDRYL-CONTAINING AMINO COMPOUND BY USING BANDAGE HAVING NAIL SHAPED CAVITY | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 1997-12-09 | — | — | US | claimed |
| EP-0755675-B1 | Dermatological and/or pharmaceutical composition, process of preparation and utilization | OREAL (FR) | 1997-09-17 | — | — | EP | claimed |
| EP-0792137-A1 | ANTIFUNGAL TREATMENT OF NAILS | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1997009973-A2 | PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-03-20 | — | — | WO | claimed |
| WO-1996036739-A1 | COMBINATIONS OF ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-11-21 | — | — | WO | claimed |
| WO-1996019186-A1 | ANTIFUNGAL TREATMENT OF NAILS | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 1996-06-27 | — | — | WO | claimed |
| US-5407663-A | Swishing solution in mouth, expectorating | EISEN DRORE (US) | 1995-04-18 | — | — | US | claimed |
| EP-0389778-B1 | Nail Varnish | HOFFMANN LA ROCHE (CH) | 1994-05-04 | — | — | EP | claimed |
| EP-0024334-B1 | MORPHOLINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-07-20 | — | — | EP | claimed |
| EP-0024334-A1 | Morpholine derivatives, process for their production, pharmaceutical preparations containing these derivatives | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-03-04 | — | — | EP | claimed |